Evidence, ethics and trust: four conversations shaping transplantation practice

Progress in transplantation depends on more than technical innovation. New evidence must improve patient outcomes, protect donors, support fair access and remain understandable to the public. Recent episodes of The Transplantation Society’s Behind the Paper series illustrate how these responsibilities intersect.
Clarifying DCD and building trust
Gabriel Gondolesi, Martí Manyalich and Steven Potter discussed their article on clarifying the donation after circulatory death process, addressing misunderstandings and correcting misinformation through education. The topic is especially timely as more countries introduce or expand DCD.
Public communication must be accurate without becoming defensive or oversimplified. It should explain the independence of end-of-life decisions, the criteria for determining death, the purpose of preservation techniques, and the safeguards that govern allocation and recovery. When professionals use inconsistent language, uncertainty can be amplified. Clear education is therefore part of programme quality, not only a communications task.
Sequential NRP and NMP in DCD liver transplantation
A conversation with Rohit Gaurav examined a retrospective single-centre experience using in situ normothermic regional perfusion followed by ex situ normothermic machine perfusion in controlled DCD liver transplantation. Sequential approaches may create additional opportunities to assess, preserve or recondition organs, but they also require careful interpretation of viability signals, logistics, resources and outcomes.
The value of this work lies not in treating one experience as a universal protocol, but in understanding how layered technologies can change clinical decision-making. Programmes considering adoption need transparent criteria, trained teams, audit and a clear plan for evaluating whether the added complexity produces meaningful benefit.
Living donor candidates and anti-obesity interventions
Babak J. Orandi discussed the ethical and policy implications of anti-obesity interventions for living organ donor candidates. The question is not simply whether weight loss may make donation possible. It also concerns voluntariness, access to treatment, cost, timing, long-term follow-up and the risk that a candidate may feel pressured to undergo an intervention for the benefit of another person.
Living donor programmes must protect the donor as an individual patient. Any pathway involving medication, surgery or intensive weight management should be based on independent counselling, realistic benefit-risk assessment and equitable access. Eligibility policies should avoid turning new treatment options into new forms of obligation.
Transplantation and survival in a South African PD-first programme
Robert Freercks and Kathryn Manning discussed evidence that transplantation improves patient survival within a peritoneal-dialysis-first programme in South Africa. The setting matters. In resource-constrained systems, dialysis modality, transplant access and service capacity are linked, and comparisons should be understood within the actual pathways available to patients.
The study reinforces a broader systems lesson: the benefit of transplantation is realised only when patients can be identified, evaluated, listed and transplanted within a functioning pathway. Improving outcomes therefore requires both clinical excellence and service design.
A common lesson
These conversations address different problems, but the underlying principle is consistent: evidence and ethics cannot be separated. Better technology without trustworthy governance can undermine confidence; good intentions without data can perpetuate ineffective practice. Sustainable systems need professionals who can interpret evidence, communicate clearly and make decisions within ethical and organisational frameworks.
DTI Foundation’s TPM Advanced International Training Course uses case discussion, simulation and multidisciplinary learning to help professionals connect these dimensions in practice. The goal is not only to know what is new, but to decide when, how and under which safeguards it should be implemented.
Related learning: Explore TPM Advanced 2026
Sources and further reading
TTS: Clarifying the DCD process
TTS: Sequential NRP and NMP in DCD liver transplantation
TTS: Anti-obesity interventions in living organ donor candidates
TTS: Transplantation improves survival in a PD-first programme






